grant

Therapeutical potential and mechanisms of action of new compounds from bitter melon for insulin resistant states [ 2008 - 2008 ]

Also known as: Bitter melon-derived compounds have beneficial effects for diabetes

Funded by National Health and Medical Research Council
Managed by Garvan Institute of Medical Research
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/481334]

Researchers: Prof Jiming Ye (Principal investigator) ,  Prof Edward Kraegen

Brief description Type 2 Diabetes is a major disease with major economic and health implications. Current medications are either insufficient or have serious adverse effects. Bitter melon is a vegetable in many countries including Australia and it has been used as a traditional medicine to control blood sugar. This project intends to identify the active ingredients from bitter melon for the treatment of type 2 diabetes. The results will indicate their potential as new agents for this disease.

Funding Amount $AUD 115,155.00

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
329903 | Dyslipidaemia | GLUT4 translocation | Hypoglycaemic effects: efficacy and mechanisms | Insulin Resistance | Insulin resistance | Metabolic Syndrome | Obesity | Traditional medicines | Type 2 diabetes | tyrosine kinase, c-Cbl, PYK2 |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA